Cross-protection induced by VA-MENGOC-BC® vaccine-Reference-Cited by-同舟云学术

Cross-protection induced by VA-MENGOC-BC® vaccine

Published:2018-02-26 Issue:5 Volume:14 Page:1064-1068
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Ochoa-Azze Rolando Felipe¹^ORCID

Affiliation:

1. Department of Immunology, Institute of Basic and Preclinical Sciences, University of Medical Sciences, Senior Researcher at the Finlay Institute of Vaccines, Havana, Cuba

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2018.1438028

Reference32 articles.

1. Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines

2. Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serogroup B Protein Meningococcal Vaccines and the Formation of Immune Protection against Gonorrhea;Epidemiology and Vaccinal Prevention;2024-07-10

2. Gonococci – Pathogens of Growing Importance. Part 2. Virulence Factors, Antimicrobial Resistance and Vaccine Development;Advancements of Microbiology;2024-06-01

3. Isolation of Extracellular Outer Membrane Vesicles (OMVs) from Escherichia coli Using EVscore47 Beads;Molecules;2024-04-17

4. Evaluating vaccine-elicited antibody activities against Neisseria gonorrhoeae : cross-protective responses elicited by the 4CMenB meningococcal vaccine;Infection and Immunity;2023-12-12

5. Human monoclonal antibodies reveal subdominant gonococcal and meningococcal cross-protective antigens;2023-12-08